SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Leerink Partners Downgrades Veracyte to Market Perform From Outperform

Leerink Partners lowered its rating on Veracyte to Market Perform from Outperform and set a $35 price target.

VCYT

Related stories